Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “mTOR”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02619864
What this trial is testing

MTORC1/mTORC2 Kinase Inhibitor AZD2014 in Previously Treated Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Canadian Cancer Trials Group 15
Early research (Phase 1)Study completedNCT01545947
What this trial is testing

Study Assessing Safety, Pharmacokinetics and Efficacy of CC-223 With Either Erlotinib or Oral Azacitidine in Advanced Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell LungNon-Small Cell Lung Cancer
Celgene 76
Testing effectiveness (Phase 2)Study completedNCT00079235
What this trial is testing

CCI-779 in Treating Patients With Stage IIIB (With Pleural Effusion) or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Recurrent Non-small Cell Lung CancerStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
National Cancer Institute (NCI) 50
Early research (Phase 1)Study completedNCT01154335
What this trial is testing

Everolimus and OSI-906 for Patients With Refractory Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
SCRI Development Innovations, LLC 18
Large-scale testing (Phase 3)Study completedNCT04047576
What this trial is testing

Study of Sirolimus in Idiopathic Retroperitoneal Fibrosis

Who this might be right for
Retroperitoneal Fibrosis
Peking University International Hospital 64
Testing effectiveness (Phase 2)Study completedNCT00093080
What this trial is testing

Study of AP23573/MK-8669 (Ridaforolimus), A Mammalian Target of Rapamycin (mTOR) Inhibitor, in Participants With Advanced Sarcoma (MK-8669-018 AM1)(COMPLETED)

Who this might be right for
LeiomyosarcomaLiposarcomaOsteosarcoma+2 more
Merck Sharp & Dohme LLC 216
Early research (Phase 1)WithdrawnNCT01383668
What this trial is testing

Sirolimus and Gold Sodium Thiomalate in Treating Patients With Advanced Squamous Non-Small Cell Lung Cancer

Who this might be right for
Recurrent Non-small Cell Lung CancerSquamous Cell Lung CancerStage IIIA Non-small Cell Lung Cancer+3 more
Mayo Clinic
Early research (Phase 1)WithdrawnNCT01332279
What this trial is testing

Everolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation Therapy

Who this might be right for
Recurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland CancerRecurrent Squamous Cell Carcinoma of the Hypopharynx+8 more
Fox Chase Cancer Center
Not applicableLooking for participantsNCT06535568
What this trial is testing

Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38)

Who this might be right for
Coronary DiseaseHeart DiseasesCardiovascular Diseases+22 more
Fondazione Ricerca e Innovazione Cardiovascolare ETS 576
Testing effectiveness (Phase 2)Study completedNCT00770120
What this trial is testing

S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery

Who this might be right for
Malignant Mesothelioma
SWOG Cancer Research Network 61
Early research (Phase 1)Ended earlyNCT00337376
What this trial is testing

The mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination With Abraxane in Advanced Solid Cancers

Who this might be right for
Advanced Solid Cancers
Yale University 23
Testing effectiveness (Phase 2)Study completedNCT04094675
What this trial is testing

Sirolimus for Cowden Syndrome With Colon Polyposis

Who this might be right for
PTEN Gene MutationPTEN Hamartoma Tumor SyndromePTEN Hamartoma Syndrome+4 more
Ohio State University 5
Testing effectiveness (Phase 2)Study completedNCT00331409
What this trial is testing

Everolimus and Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer

Who this might be right for
Kidney Cancer
OHSU Knight Cancer Institute 23
Post-approval studies (Phase 4)Ended earlyNCT01561404
What this trial is testing

Effect of the Inhibition of the Mammalian Target of Rapamycin on Metabolism and Exercise

Who this might be right for
Disorder Related to Renal TransplantationExercise, AerobicMuscle Strength
Josep M Cruzado 3
Early research (Phase 1)Study completedNCT02193633
What this trial is testing

A Phase I Trial of the Combination of AZD2014 and Weekly Paclitaxel.

Who this might be right for
Advanced Cancer
Royal Marsden NHS Foundation Trust 90
Early research (Phase 1)Study completedNCT01548807
What this trial is testing

Phase 1 Trial of the Mammalian Target of Rapamycin (mTOR) Inhibitor Everolimus Plus Radiation Therapy (RT) for Salvage Treatment of Biochemical Recurrence in Prostate Cancer Patients Following Prostatectomy

Who this might be right for
Prostate Cancer Patients With Detectable PSA Following Prostatectomy
Abramson Cancer Center at Penn Medicine 19
Testing effectiveness (Phase 2)Ended earlyNCT01412515
What this trial is testing

A Phase II Study With Tumor Molecular Pharmacodynamic (MPD) Evaluation of Oral mTOR-inhibitor Everolimus (RAD001) 10 mg Daily in Patients Suffering From Classic or Endemic Kaposi's Sarcoma

Who this might be right for
Kaposi Sarcoma
Institut National de la Santé Et de la Recherche Médicale, France 11
Testing effectiveness (Phase 2)Study completedNCT00122343
What this trial is testing

AP23573 in Female Adult Patients With Recurrent or Persistent Endometrial Cancer (8669-019)(COMPLETED)

Who this might be right for
Endometrial Cancer
Merck Sharp & Dohme LLC 45
Testing effectiveness (Phase 2)Ended earlyNCT02987959
What this trial is testing

Study of TAK-228 (MLN0128) in Soft Tissue Sarcomas

Who this might be right for
Soft-tissue Sarcoma
Fox Chase Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT01665768
What this trial is testing

Maintenance Rituximab With mTor Inhibition After High-dose Consolidative Therapy in Lymphoma

Who this might be right for
CD20+, B-cell LymphomasMantle Cell LymphomaNon-Mantle Cell Low Grade B Cell Lymphomas (SLL/CLL)+3 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 56
Next Page